The study compared the two treatments among 89 patients who previously underwent failed conservative treatment for tendinopathies of the elbow, quadriceps, patellar and Achilles tendons, as well as plantar fasciopathy. Forty-two of the patients were treated with mcRF and 47 patients were treated with PRP.
There were 33 patients in both groups who showed marked improvement, representing 28 percent and 70 percent of the mcRF and PRP groups, respectively.
More Articles on Orthopedic Devices:
DePuy Spine Launches Pedicular Screw System for Spinal Fusions
Medtronic Launches Electronic Power Instruments for Spinal Surgery
17 Spine Devices Receive FDA 510(k) Clearance in March
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
